1 Daniel J. Benedetti, MD, MA, Division of Pediatric Hematology/Oncology, and Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, TN; Jonathan M. Marron, MD, MPH, Division of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, and Center for Bioethics, Harvard Medical School, Boston, MA; Stefanie M. Thomas, MD, MS, Department of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Cleveland Clinic, Cleveland, OH; Amy E. Caruso Brown, MD, MSc, MSCS, Division of Pediatric Hematology/Oncology, and Center for Bioethics and Humanities, SUNY Upstate Medical University, Syracuse, NY; Kimberly A. Pyke-Grimm, PhD, Department of Nursing Research and Evidence-Based Practice, Stanford Children's Health and Division of Pediatric Hematology/Oncology, Stanford University School of Medicine, Palo Alto, CA; Liza-Marie Johnson, MD, MPH, MSB, Department of Oncology, St Jude Children's Research Hospital, Memphis, TN; Eric Kodish, MD, Departments of Pediatrics, Oncology, and Bioethics, Cleveland Clinic Children's and Case Western Reserve University, Cleveland, OH; and Yoram Unguru, MD, MS, MA, Division of Pediatric Hematology/Oncology, The Herman and Walter Samuelson Children's Hospital at Sinai, Baltimore, MD, Johns Hopkins University Berman Institute of Bioethics, Baltimore, MD.